ReAlta Life Sciences

Norfolk, United States

ReAlta is a clinical-stage biotech company that develops a new class of drugs to address life-threatening diseases.

Apr 2026

Undisclosed

Biotechnology Life Science Pharmaceutical

Top Investors

National Institute of Allergy and Infectious DiseasesVirginia CatalystMarathon PharmaceuticalsChildren’s Research Holdings

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ReAlta Life Sciences

Who are ReAlta Life Sciences's investors?

ReAlta Life Sciences's investors include National Institute of Allergy and Infectious Diseases, Virginia Catalyst, Marathon Pharmaceuticals, Children’s Research Holdings.

Where is ReAlta Life Sciences headquartered?

ReAlta Life Sciences is headquartered in Norfolk, United States.

What does ReAlta Life Sciences do?

ReAlta is a clinical-stage biotech company that develops a new class of drugs to address life-threatening diseases.

What stage is ReAlta Life Sciences at?

ReAlta Life Sciences is at the Undisclosed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 8, 2026.

MLA

"ReAlta Life Sciences — Funding & Investors." VCBacked, April 8, 2026, https://www.vcbacked.co/company/realta-life-sciences. Accessed June 3, 2026.

APA

VCBacked. (2026). ReAlta Life Sciences — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/realta-life-sciences

Wikipedia (cite web)

{{cite web |title=ReAlta Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/realta-life-sciences |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 8, 2026.